Linden Thomas Advisory Services LLC Has $664,000 Position in DocuSign, Inc. (NASDAQ:DOCU)

Linden Thomas Advisory Services LLC lifted its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 2.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 11,177 shares of the company’s stock after purchasing an additional 318 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in DocuSign were worth $664,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Greenwich Wealth Management LLC raised its holdings in shares of DocuSign by 7.7% during the fourth quarter. Greenwich Wealth Management LLC now owns 92,748 shares of the company’s stock worth $5,514,000 after acquiring an additional 6,650 shares during the period. abrdn plc boosted its position in DocuSign by 96.7% during the 4th quarter. abrdn plc now owns 74,233 shares of the company’s stock worth $4,413,000 after acquiring an additional 36,488 shares during the last quarter. Resonant Capital Advisors LLC grew its stake in shares of DocuSign by 34.8% during the 4th quarter. Resonant Capital Advisors LLC now owns 17,300 shares of the company’s stock worth $1,028,000 after acquiring an additional 4,464 shares in the last quarter. Telos Capital Management Inc. acquired a new stake in shares of DocuSign in the fourth quarter valued at approximately $575,000. Finally, Rakuten Securities Inc. bought a new stake in shares of DocuSign in the fourth quarter worth $151,000. 77.64% of the stock is owned by institutional investors.

DocuSign Stock Up 0.1 %

DocuSign stock opened at $57.35 on Friday. The business’s 50-day moving average price is $56.35 and its two-hundred day moving average price is $52.55. DocuSign, Inc. has a 12-month low of $38.11 and a 12-month high of $64.76. The stock has a market cap of $11.78 billion, a PE ratio of 159.31, a P/E/G ratio of 5.01 and a beta of 0.89.

DocuSign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The company had revenue of $712.39 million during the quarter, compared to the consensus estimate of $698.05 million. As a group, analysts expect that DocuSign, Inc. will post 0.86 earnings per share for the current year.

Analysts Set New Price Targets

DOCU has been the topic of a number of recent research reports. Wells Fargo & Company lowered their target price on DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research report on Monday, February 5th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, April 12th. JMP Securities restated a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a research note on Friday, April 12th. Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $49.00 to $64.00 in a research note on Tuesday, January 16th. Finally, UBS Group raised shares of DocuSign from a “sell” rating to a “neutral” rating and increased their price objective for the company from $48.00 to $62.00 in a research report on Friday, April 12th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, DocuSign presently has an average rating of “Hold” and a consensus target price of $60.25.

Insider Buying and Selling at DocuSign

In other news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the transaction, the chief executive officer now owns 111,767 shares in the company, valued at $6,847,964.09. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CEO Allan C. Thygesen sold 7,680 shares of DocuSign stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the transaction, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Teresa Briggs sold 499 shares of the company’s stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $52.99, for a total transaction of $26,442.01. Following the sale, the director now directly owns 6,169 shares in the company, valued at approximately $326,895.31. The disclosure for this sale can be found here. In the last ninety days, insiders sold 54,871 shares of company stock worth $3,176,199. 17.80% of the stock is currently owned by company insiders.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.